Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.41 |
| ▸ | BLM | P54132 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.37 |
| ▸ | GSR | P00390 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | HBB | P68871 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.31 |
| ▸ | GABRP | O00591 | 1/20 | 0.31 |
| ▸ | GABRD | O14764 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28723280 | 0.83 | BLM (0.41) | APPCPB2BLMLMNASLC6A6 | |
| SCHEMBL28688857 | 0.83 | TP53 (0.37) | TP53 | |
| SCHEMBL4729598 | 0.77 | APP (0.44) | APPCPB2BLMLMNASLC6A6 | |
| Sulfuric Acid SCHEMBL1833456 | 0.77 | APP (0.39) | APPCPB2BLMLMNASLC6A6 | |
| Sulfuric Acid SCHEMBL1833455 | 0.77 | APP (0.39) | APPCPB2BLMLMNASLC6A6 | |
| SCHEMBL27970870 | 0.77 | CA12 (0.48) | LMNACYP2C19PMP22TSHRTHPO | |
| SCHEMBL27970857 | 0.77 | CA12 (0.48) | LMNACYP2C19PMP22TSHRTHPO | |
| SCHEMBL1628827 | 0.75 | APP (0.42) | APPCPB2BLMLMNASLC6A6 | |
| SCHEMBL19066306 | 0.75 | APP (0.42) | APPCPB2BLMLMNASLC6A6 | |
| SCHEMBL7028928 | 0.75 | TP53 (0.43) | APPCPB2BLMLMNASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030095924-A1 | Galenical formulations | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030095924-A1 | Galenical formulations | GALR1, GALR2, LGALS1 | APP 1196/4885CPB2 1365/4885BLM 2260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.